The global expansion of the cosmetic and beauty industry with the rising demand for aesthetics and cosmetic procedures and surging product approvals from various regulatory bodies are significantly boosting the growth of the global botulinum toxin market.

According to a new research report by Next Move Strategy Consulting, the global botulinum toxin market was valued at USD 6.6 billion in 2023, and is expected to reach USD 11.68 billion by 2030, with a CAGR of 8.51% during the forecast period, 2024–2030.

The continuous stream of product approvals from various regulatory bodies drives the botulinum toxin market. These approvals provide a green light for manufacturers to introduce new and improved botulinum toxin-based products to the market. For instance, in August 2023, the U.S. Food and Drug Administration (FDA) approved the first therapeutic indication of Revance's DAXXIFY (DaxibotulinumtoxinA for Injection), specifically for the treatment of cervical dystonia.

This approval of DAXXIFY for cervical dystonia marks a significant milestone in expanding its applications beyond the cosmetic use. Thus, such kind of endorsement from regulatory authorities enhances the overall credibility of aesthetic treatments, encouraging widespread adoption and contributing to the market's expansion.

Moreover, the expansion of the cosmetic and beauty industry due to the rising demand for aesthetics and cosmetic procedures is significantly fueling the market growth. According to the latest survey by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2023, there was an overall increase of 11.2% in procedures conducted by plastic surgeons in 2022.

These procedures included more than 14.9 million surgical and 18.8 million non-surgical treatments performed globally. The expanding cosmetic industry is fueling the demand for these procedures, consequently driving the growth in the botulinum toxin market. Furthermore, in June 2023, Evolus, Inc. launched Nuceiva, a botulinum toxin type A product, in the Italian market. Nuceiva is designed for various aesthetic treatments, and its launch in Italy expands its availability. It offers new options for medical professionals and patients seeking cosmetic enhancements. This expansion signifies Evolus Inc.'s commitment to providing innovative solutions in the field of botulinum toxin products.

Additionally, in May 2023, Daewoong Pharmaceutical, a South Korean pharmaceutical company, invested USD 746 million to expand its production capacity for Botox, a brand of botulinum toxin. This significant investment aims to meet the growing global demand for cosmetic and therapeutic uses of Botox. Daewoong's expansion reflects the rising interest in botulinum toxin products and their applications, indicating a positive trend in the market's growth and development.

However, adverse effects such as skin reactions, allergies, swallowing difficulties, and neck discomfort limit the botulinum toxin market growth. Patient concerns about safety and well-being hinder the market growth. Addressing these issues through research and development is vital for market players to ensure the continued acceptance and expansion of botulinum toxin applications in therapeutic and aesthetic treatments.

On the contrary, the introduction of new botulinum toxins, such as the DaxibotulinumtoxinA for Injection and Jeuveau, creates significant growth opportunities for the market. These advanced products offer improved performance and safety, meeting the rising demand for better therapeutic and aesthetic treatments.

Request a sample here: https://www.nextmsc.com/botulinum-toxin-market/inquire-before-buying   

According to the report, leading players operating in the botulinum toxin market include Allergan, Inc., Merz Pharma GmbH & Co. KGaA, Ipsen Group, Revance Therapeutics, Inc., Medy-Tox, Inc., Hugel, Inc., Galderma, Us Worldmed, Llc, Evolus, Inc., Daewoong Pharmaceutical, and others.  

Key Insights from the Botulinum Toxin Market Report:

• The information related to key drivers, restraints, and opportunities and their impact on the botulinum toxin market is provided in the report.

• The value chain analysis in the market study provides a clear picture of the roles of each stakeholder.

• The market share of the players in the global botulinum toxin market and its competitive analysis are provided in the report.